IFIT1 (IFN-induced protein with tetratricopeptide repeats-1) is an effector of the host innate immune antiviral response that prevents propagation of virus infection by selectively inhibiting translation of viral mRNA. It relies on its ability to compete with the translation initiation factor eIF4F to specifically recognize foreign capped mRNAs, while remaining inactive against host mRNAs marked by ribose 2′-O methylation at the first cap-proximal nucleotide (N1). We report here several crystal structures of RNA-bound human IFIT1, including a 1.6-Å complex with capped RNA. IFIT1 forms a water-filled, positively charged RNA-binding tunnel with a separate hydrophobic extension that unexpectedly engages the cap in multiple conformations (syn and anti) giving rise to a relatively plastic and nonspecific mode of binding, in stark contrast to eIF4E. Cap-proximal nucleotides encircled by the tunnel provide affinity to compete with eIF4F while allowing IFIT1 to select against N1 methylated mRNA. Gel-shift binding assays confirm that N1 methylation interferes with IFIT1 binding, but in an RNA-dependent manner, whereas translation assays reveal that N1 methylation alone is not sufficient to prevent mRNA recognition at high IFIT1 concentrations. Structural and functional analysis show that 2′-O methylation at N2, another abundant mRNA modification, is also detrimental for RNA binding, thus revealing a potentially synergistic role for it in self-versus nonself-mRNA discernment. Finally, structure-guided mutational analysis confirms the importance of RNA binding for IFIT1 restriction of a human coronavirus mutant lacking viral N1 methylation. Our structural and biochemical analysis sheds new light on the molecular basis for IFIT1 translational inhibition of capped viral RNA.
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IFIT1 crystal structure | innate immunity | mRNA cap recognition | self vs. nonself | 2′-O methylation I nfection by a virus relies on its ability to exploit the host's translational machinery to convert its genome into protein products that can ultimately be used to assemble new viral particles. In eukaryotes, endogenous mRNA is protected by a highly conserved 5′ cap structure consisting of an N7-methylguanosine triphosphate (m7Gppp/Cap0) moiety. This is recognized by the eukaryotic translation initiation factor 4E to promote capdependent translation (eIF4E together with eIF4G and eIF4A comprise eIF4F) (1) . In higher eukaryotes, the mRNA cap is further modified by ribose 2′-O methylation on the first and sometimes second cap-proximal nucleotides (N1 and N2, where N is any nucleotide) (Fig. S1A) , resulting in Cap1-(m7GpppNmN) or Cap2-(m7GpppNmNm) mRNA (2, 3) . N1 methylation was recently shown to serve as a molecular signature of "self," which can subvert mammalian antiviral responses (4, 5) . As such, many viruses also produce Cap1-mRNA, either through the action of host-or virally encoded 2′-O methyltransferases (MTases) or through viral "cap-snatching" enzymes (6, 7) . Hence, Cap0-mRNAs (along with other virus-derived RNAs) are marked as "nonself" and can trigger responses, such as the type I IFN antiviral program (5, 8, 9) , which culminates in the induction of hundreds of IFN-stimulated genes (ISGs) (10) .
Among the most potently induced of the ISGs are the IFITs (IFN-induced proteins with tetratricopeptide repeats), a family of antiviral effectors whose expression can also be triggered downstream of IFN-independent signaling (11) . IFITs are conserved throughout vertebrate evolution, with humans and most mammals encoding five paralogues-IFIT1, IFIT1B, IFIT2, IFIT3, and IFIT5-although many also possess species-specific duplications and deletions. For example, mice lack IFIT5 and were only recently discovered to have also lost IFIT1 (12) . Therefore, what is currently known as mouse Ifit1 (54% sequence identity with human IFIT1) is actually an ortholog of human IFIT1B. In humans, IFIT1B (67% sequence identity with human IFIT1) is not known to be IFN-inducible (11) , and recent data suggest that it may be nonfunctional (12) . IFITs are structurally related and are composed of tandem copies of the tetratricopeptide repeat (TPR), a helix-turn-helix motif. Structures of several IFITs have shown that their TPRs coalesce into distinct superhelical subdomains that form clamp-shaped structures (13) (14) (15) (16) .
Significance
IFIT1 is an antiviral effector of host innate-immunity that selectively recognizes the 5′-end of viral mRNAs, which are often capped to mimic host mRNA, and blocks their translation. Our X-ray structural analysis reveals that the cap and four additional nucleotides are encircled by IFIT1 through a central tunnel in an adaptable manner, which gives it the flexibility required to defend against many different viruses, and to deter their ability to rapidly evolve. Host mRNA, normally ribose methylated at the first and second nucleotides following the cap, avoids IFIT1 recognition through tight complementary interfaces at these positions. This study uncovers the molecular basis for how IFIT1 selectively recognizes viral mRNAs and will help guide development of viral vaccines and mRNA therapeutics.
Recently, it was discovered that IFITs play a prominent role in impeding viral replication by directly binding the 5′ end of viral RNA (17) . Thus, IFIT1 and IFIT1B can compete with eIF4F to selectively bind and sequester viral Cap0-mRNA, resulting in its translational inhibition (18) (19) (20) . In this manner, mouse Ifit1 has been shown to restrict a broad spectrum of wild-type and mutant viruses lacking 2′-O MTase activity, including alphaviruses, coronaviruses, flaviviruses, and vaccinia virus (4, 18, (21) (22) (23) (24) (25) , whereas mutating viral N1 methylation enhanced coronavirus and flavivirus sensitivity to human IFIT1 (18, 23, 24, 26) . In contrast, host cellular mRNA is not targeted as it bears N1 2′-O methylation, which interferes with IFIT1 and IFIT1B binding (18) (19) (20) . That many cytoplasmic virus families have adapted by acquiring 2′-O MTases to generate their own Cap1-mRNA, thereby potentially escaping IFIT1/IFIT1B restriction, underscores the importance of these proteins in this process (7) . Furthermore, alphaviruses, which display only Cap0-mRNA, can still subvert mouse Ifit1 activity by encoding capproximal structural elements (21, 22) , which has also been shown to interfere with RNA binding and enhance pathogenicity.
IFIT1, along with IFIT5, can also recognize uncapped viral triphosphate (PPP)-RNA (another nonself marker of infection) to potentially inhibit the replication of some negative-sense singlestranded (ss) RNA viruses (13, 17) . The crystal structure of human IFIT5 bound to uncapped PPP-RNA revealed that the RNA sits in a narrow, positively charged tunnel at the core of the protein, with a network of electrostatic interactions specifically recognizing the PPP moiety (13) . Up to four nucleotides are also stably bound within the tunnel in a sequence-nonspecific manner. The sequence identity between IFIT5 and IFIT1 (55%) and a structure of the N-terminal region of IFIT1 suggested that IFIT1 accommodates capped RNA in a similar fashion. However, IFIT5 cannot bind capped mRNA (13, 18, 19) , and indeed protein residues at the base of the tunnel would block any further progression beyond the PPP moiety. Thus, how IFIT1-like proteins can accommodate Cap0-mRNA remains unclear.
We report here several crystal structures of RNA-bound human IFIT1. The structures reveal that the positively charged RNA-binding tunnel of IFIT1 is distinct from that found in IFIT5 and further extended to allow binding of both capped and uncapped RNAs. Strikingly, mRNA binding and cap recognition by IFIT1 appears to be adaptable and its mechanism is evolutionarily divergent from eIF4E and other cap-binding proteins. The shape of the tunnel in the vicinity of the 2′-hydroxyls of N1 and N2 sterically occludes RNA methylated at these positions. A comprehensive analysis of the interaction between human IFIT1 and differentially methylated capped RNAs corroborates the structural findings, revealing that either N1 or N2 methylation alone interferes with IFIT1 binding, but in an RNA-dependent manner. Combining N1 and N2 methylation resulted in an additive and potentially synergistic effect in inhibiting IFIT1 activity, particularly toward susceptible RNA sequences and at high IFIT1 concentrations. Our structural and biochemical analysis therefore sheds light on IFIT1 antiviral activity and reveals a previously uncharacterized role for N2 ribose methylation and Cap2 structures as signatures of self mRNA.
Results

RNA Binding and Inhibition of in Vitro Translation by Human IFIT1.
The interaction between IFIT1 and capped-RNA is well established, but the precise structural determinants of the viral RNA important for binding are as yet unclear. Thus, we began by carrying out EMSAs between human IFIT1 and two 5′ capped sequences derived from genomes of coronaviruses known to be restricted by human IFIT1 or mouse Ifit1: human coronavirus strain 229E (HCoV) and murine hepatitis virus strain A59 (MHV) (18) . Human IFIT1 bound the capped-RNAs with apparent affinities of ∼250 nM and <100 nM, respectively (Fig. 1A) . Binding strength decreased as the stability and proximity of RNA secondary structure to the 5′-end increased (Fig.  1A and Fig. S1B ), confirming the preference for ssRNA as previously demonstrated for human IFIT1 and mouse Ifit1 (13, 21) . As with IFIT5, RNA binding is generally sequence-nonspecific and replacing the first 3 nt of HCoV (sequence ACU) with GGG resulted in only a modest enhancement of binding (Fig. 1A, Right) . IFIT1 also binds uncapped PPP-RNA, but this is inherently weaker and more sensitive to the presence of predicted secondary structure at the 5′-end (Fig.  S1C ). This finding is in contrast to IFIT5, which binds PPP-RNA but cannot accommodate capped RNA, as shown by its crystal structure and a variety of biochemical assays from several groups (13, 18, 19) .
To understand the contribution of IFIT1 binding to capped RNA in a more physiological context, we used an in vitro translation system to assess the effect on translation initiation. The system consists of Krebs extracts programmed with a bicistronic Cap0-mRNA reporter (27) . The 5′-cistron expresses a Firefly luciferase (FF) reporter that is translated in a cap-dependent manner, whereas the 3′-cistron expresses a Renilla luciferase (Ren) reporter under the control of an internal ribosome entry site (IRES) from hepatitis C virus (HCV) (Fig. 1B) . Ren expression serves as an internal control for nonspecific translational inhibition by IFIT1. Titrating human IFIT1 into these extracts at concentrations ranging from ∼30 nM to 5 μM showed that IFIT1 could inhibit Cap0-dependent translation with IC 50 values of ∼50-200 nM (Fig. 1C, and other figures herein) . Interestingly, addition of IFIT1 after the reporter was preincubated with translation extracts for 10 min resulted in its inhibitory activity being reduced by more than an order-of-magnitude (IC 50 > 5 μM), presumably because of the formation of a closed-loop mRNP that facilitates ribosome reinitiation (28) . This result suggests that optimal IFIT1 activity in vivo is probably only realized in cells that are already expressing the protein before infection, as might be the case for cells activated by IFN signaling in a paracrine manner.
In all cases, cap-independent translation of Ren was reduced by at most 15-20%, which is likely because of nonspecific binding of IFIT1 to either the IRES, ribosomal RNA (19) , transfer RNA (19) , or translation factors (e.g., eIF3e) (29) . This finding is in contrast to one report showing nearly complete inhibition of HCV-IRES-mediated translation by 600 nM IFIT1 in rabbit reticulocyte lysates (30) . This discrepancy may be attributed to differences in translation efficiency between Krebs extracts and rabbit reticulocyte lysates. Finally, titration of IFIT5 in these assays did not produce the same level of translational inhibition ( Fig. S1D ) (IC 50 ≥ 5 μM), consistent with the notion that IFIT5 cannot specifically bind capped-RNA. Taken together, our data are consistent with an IFIT1 antiviral mechanism that is dependent on the recognition of mRNA cap structures to compete with eIF4F (18, 19) . Overall Structure of Full-Length Human IFIT1. To gain insight into the mechanisms of viral RNA binding by IFIT1, we initially crystallized RNA-bound, full-length, wild-type human IFIT1 (residues 1-478) in complex with short PPP-and m7Gppp-containing oligoadenosines. The IFIT1-RNA complex purified and crystallized as a dimer with two molecules in the asymmetric unit, but diffracted X-rays to only ∼2.7 Å. To improve the resolution, we mutated the dimerization interface at the C-terminal end of the protein to produce a monomeric version that crystallized in a different space group and diffracted X-rays to 1.58-Å resolution (Table S1 ). The overall folds of the wild-type and monomeric mutant are essentially the same (rmsd 0.35 Å). Henceforth, we describe only the high-resolution structures with respect to RNA binding, whereas all functional assays were performed with wild-type protein.
Human IFIT1 is made up of 23 α-helices, 18 of which form 9 TPR motifs that together form three distinct subdomains interrupted by non-TPR structural elements ( Fig. 2 A and B and Fig. S2 A-C) . The overall structure is similar to the previously determined RNA-bound structure of human IFIT5 (rmsd 1.9 Å) (Fig. S2D ) and the N-terminal region of human IFIT1 (rmsd 0.8 Å) (Fig. S2E) (13) . The subdomains are arranged to form a clamp-shaped structure with a central RNA-binding tunnel that is ∼30-40 Å in length and 12-19 Å in width, accommodating only ssRNA with a total of five nucleotides (cap + four RNA nucleotides) (Fig. 2 B-D) . As with IFIT5, a pair of long non-TPR pivot helices connect the second and third subdomains and likely function in an analogous fashion to regulate closure of the protein around the RNA (13) (Fig. S2C) . About 30-40% of the tunnel volume is occupied by bound water molecules (Fig. 2E ), which appears to be an important facet for recognition of different RNA sequences and structures (discussed below). We demarcate four distinct regions of the tunnel according to their role in RNA binding: (i) the cap-binding pocket, which houses the N7-methylguanosine moiety; (ii) the triphosphate channel, which links the cap-binding pocket to the 5′-end of the RNA; (iii) the first dinucleotide (N1 and N2), where the presence of 2′-O methylation is sensed; and (iv) the second dinucleotide (N3 and N4), where the requirement for single stranded 5′-ends is reinforced.
The IFIT1 RNA-Binding Tunnel Houses a Functionally Distinct CapBinding Pocket. IFIT1 and IFIT5 were previously characterized as PPP-RNA binding proteins (17) , although more recent evidence revealed that the primary role of IFIT1 is in binding capped-RNA. Conversely, the role of IFIT5 remains restricted to recognition of 5′-phosphorylated RNAs (13, 14, 16) . The structure of IFIT1 bound to PPP-RNA revealed that, like IFIT5, the PPP moiety is ligated by numerous specific electrostatic interactions from protein side chains (Fig. S3 A-C) . However, there are some key differences. IFIT5 recognition of PPP-RNA uses a positively charged metal ion bound between the α-and γ-phosphates, which stabilizes a bent conformation of the PPP facilitated by T37 at the base of the tunnel in IFIT5 (Fig. 3A) . The corresponding position in IFIT1 is occupied by an arginine (R38), and an ion is no longer part of its PPP binding. This results in a more extended conformation of the PPP that allows it to reach toward the entrance of a neighboring unoccupied pocket.
The crystal structure of IFIT1 bound to m7Gppp-RNA revealed that this adjacent pocket harbors the cap moiety. Whereas most of the RNA-binding tunnel is positively charged, the cap-binding pocket is generally more hydrophobic and interactions with the cap occur predominantly through nonspecific van der Waals contacts (Figs. 2C and 3B) . Surprisingly, we found that the m7G base adopts both syn-and anti-conformations with approximately equal occupancies ( Fig. 3C and Fig. S3D ) (discussed in detail below). In either conformation, m7G sits atop a tryptophan residue (W147) making π-π stacking interactions, reminiscent of other cap-binding proteins, such as eIF4E (31) (Fig. 3 D and E) . Additionally, the base is abutted by I183 from the same side as W147, and on the other side by L46 and T48 emanating from a flexible loop that forms the outer wall of the pocket, which we term the "cap-binding loop" (Fig. 3 D and E and Fig. S2F ). The ribose of m7G is similar in the syn-and anti-modes of binding, adopting an S-type conformation that is stabilized by an intramolecular hydrogen bond between the ribose 3′-OH and the bridging β-phosphate (Fig. S3D ). It sits in a pocket formed by Q42, L46, R187, Y218, I183, and L150 (Fig. 3E) , and two ordered water molecules: the first coordinated by Q42 and the second bridging the ribose 3′-OH to the backbone carbonyl of W147 (Fig. S3F) .
As in PPP-RNA-bound IFIT1, the bridging triphosphate in the cap-bound structure is in an extended conformation stabilized by numerous electrostatic interactions, although pulled slightly toward the cap-binding pocket ( Fig. 3F and Fig. S3E ). The γ-phosphate interacts with K151, R255, Y218, and R187, and the β-phosphate is coordinated by K151, R187, and R38. Additionally, six highly ordered water molecules mediate hydrogen bonds with the α-and γ-phosphates (Fig. S3F) . Finally, m7Gppp binding is facilitated by a high degree of interresidue coordination: for example, R38 is held in place by D34, and W147 is coordinated by E176 (Fig. S3G) .
In IFIT5, although most of these cap-binding residues are conserved, substitutions at a few key positions render it unable to bind cap productively. As described above, replacement of R38 in IFIT1 with T37 in IFIT5 causes it to recognize a more compact conformation of the PPP in a metal-dependent manner. This positions the γ-phosphate away from the putative cap-binding pocket, which draws in several residues, such as Q41 (from helix α2) and K48 (from the putative cap-binding loop), causing them to block access to its putative cap-binding pocket ( Fig. 3G and Fig.  S3 H and I). Therefore, the formation of a positively charged RNA-binding tunnel with an accessible and spatially separated cap-binding pocket in IFIT1 explains, at least in part, why it can bind capped-RNA, whereas IFIT5 cannot. The preference for an arginine or threonine on helix α2 is highly conserved among IFIT1/1B-like and IFIT5-like sequences, respectively (Fig. S3J) , and the identity of this PPP bridging residue (Arg or Thr) appears to play a major role in determining the 5′ specificities of IFIT1/1B-or IFIT5-like proteins. Interestingly, a small group of mammalian IFIT5-like proteins retain an arginine at this position; these sequences probably have a hybrid IFIT1/IFIT5 character, and possibly resemble an ancestral IFIT1/IFIT5 precursor protein, because they all belong to nonplacental mammals (e.g., opossum and platypus) ( electron density, which has a relatively symmetric shape because of an ∼180°rotation about the N-glycosidic bond connecting the base to the ribose. Multiple base conformations were also evident in the lower-resolution wild-type m7Gppp-RNA cocrystals. This results in the interactions at the base periphery being quite distinct in the two conformations (Fig. 4A) . Notably, there are no direct hydrogen bonds from the protein toward the base in either conformation, but there are a small number of water-mediated interactions. In the anti-orientation, N3 of the base is weakly hydrogen bonded to a water molecule that is coordinated by Q42. The N7-methyl (C7) and O6 groups make van der Waals contacts with N216, and the remainder of the base is partially oriented toward water molecules near the proximal opening of the tunnel leading to bulk solvent. In the syn-orientation, the N7-methyl and O6 are instead pointing toward the bulk solvent, whereas N2 is nestled between Y218 and N216. Because of the presence of the N7-methyl group on m7G, it acquires a delocalized positive charge on its imidazole ring that could in principle enhance the stacking with W147 through additional cation-π interactions (31, 32) . However, the geometry of cation-π stacking changes with the base orientation (Fig. 4A) . Whereas the anti-conformation places the positive charge at an angle away from W147, the syn-conformation places it directly over the indole ring of W147. To test whether N7-methylation and associated positive charge controls cap orientation, we determined the structure of Gppp-RNA (lacking the N7-methyl group) bound to IFIT1 (1.7 Å) ( Fig. 4B and Fig. S4A) . Here, the base exists only in the anti-conformation, indicating that the ability of the base to adopt two conformations depends, at least in part, on N7-methylation. The presence of two base conformations is also determined by the chemical environment surrounding the base, because the structure of an N216 mutant of monomeric IFIT1 (N216A) bound to m7Gppp-RNA also resulted in the base adopting only the anticonformation (Fig. S4B ).
Despite these observations, IFIT1 appears not to be selective for N7-methylation. In fact, gel-shift assays suggest that Gppp-RNA binding is, in some cases, more efficient than m7Gppp-RNA binding (Fig. S4C) (18, 19) , in stark contrast to the case with eIF4E, whose cap binding is strongly dependent on proper methylation (31) . In the absence of the methyl group, the guanine ring moves closer to N216, making a hydrogen bond with it through O6 (Fig. 4B, Left) , although removing this hydrogen bond through mutation (N216A or N216D) does not weaken Gppp-RNA binding (Fig. S4D) . Interestingly, the water structure surrounding Gppp-RNA changes compared with m7Gppp-RNA, such that almost all hydrogen bond donor and acceptor sites on the unmethylated base are now satisfied (Fig. 4B, Right) , and this may be a contributing factor for maintaining strong Gppp-RNA binding (relative to m7Gppp-RNA).
The physiological relevance of Gppp-RNA binding by IFIT1 is unclear, but one possibility is that it may facilitate targeting of transient intermediates formed during viral mRNA capping. We therefore tested IFIT1 activity in extracts programmed with a Gppp-capped reporter (Fig. S4E) . In this system, although overall translation is less efficient than in Cap0-programmed extracts, translation initiation still proceeds through binding of the cap-proximal nucleotides via eIF4G (33) . IFIT1 titration resulted in translational inhibition similar to m7Gppp-capped mRNA (IC 50 ∼ 200 nM), highlighting the importance of binding not only the cap, but also the proximal nucleotides to provide additional affinity to allow competition with eIF4F (19) .
Because cap binding does not rely on any guanine-specific hydrogen bonds, we wondered whether IFIT1 could also recognize Appp-capped RNAs. Indeed, IFIT1 can bind Appp-RNA (Fig.  S4F ) and inhibit translation initiation from an Appp-capped reporter (IC 50 ∼ 500 nM) (Fig. S4E) . Thus, it appears that IFIT1 has evolved to recognize not only canonically capped mRNA, but rather diverse 5′-5′ linked base modifications of the mRNA through relatively nonspecific interactions in the pocket. The notion of lack of specificity is underscored by the structure of IFIT1 with PPP-RNA, where the cap-binding pocket is occupied by PEG (polyethylene glycol) molecules from the crystallization solution, which form interactions that mimic cap binding (Fig. S4G ).
Mutational Analysis of Cap Recognition. To test whether our structural findings are functionally valid, we mutated several residues involved in cap binding and assayed them in fluorescent gel-shift binding assays (with m7Gppp-43 RNA) (Table S2) and the translational inhibition assays described above (Fig. 5 and Fig. S4I ). Both R38A and K151M are critical for binding, and K151M reduces IFIT1 inhibitory activity by one to two orders-ofmagnitude (IC 50 > 5 μM). Y218A and Q42A weakened binding to capped RNA and reduced IFIT1 inhibitory activity. N216A retains full binding to m7Gppp-RNA, indicating that the N216-cap interactions (e.g., with the N7-methyl) are dispensable. W147 is perhaps the most important residue inside the cap-binding pocket as W147M essentially abolished m7Gppp-RNA binding, whereas mutation to another aromatic residue (W147F) largely retained binding. Accordingly, W147M reduced IFIT1 translation inhibition ∼40-fold, and W147F mostly retained inhibitory activity (compared with W147M). Mutation of E176, which coordinates W147, had similar effects as W147F. From the cap-binding loop, T48 was deemed dispensable, but L46 was required for optimal binding and translational inhibition. All cap-binding pocket mutants tested here retained binding toward PPP-RNA, except for R38A and K151M (which target the PPP moiety), indicating that the protein fold was not disrupted by the mutations (Fig. S4J) . Taken together, the data in the mutational analysis confirm the importance of cap binding and the role of the RNA-binding tunnel in mediating translational inhibition by IFIT1.
Our results are in agreement with previous mutational binding assays based on in silico modeling (19) . In this model, Phe-45 and Tyr-50 from the cap-binding loop were also predicted to interact with the base; however, our structures reveal that these two residues are distal from the m7G moiety and are probably important for maintaining subdomain contacts, or helping preorganize the cap-binding loop (Fig. S4K) .
The Cap-Binding Mechanism Is Conserved in IFIT1 and IFIT1B Proteins Across Mammalian Evolution. The mode of cap binding identified here likely applies to all mammalian IFIT1-and IFIT1B-like proteins, as the residues involved in N7-methylguanosine triphosphate recognition are highly conserved (Figs. S4M and S5) . Two notably prevalent differences in cap-binding residues compared with human IFIT1 include Q42 and N216, which are replaced with a glutamate and aspartate, respectively, in many of the orthologs and paralogs (including human IFIT1B). Both substitutions are conservative, because neither would disrupt hydrogen-bonding patterns nor interfere with the van der Waals interactions with the cap. We tested this by carrying out an EMSA between m7Gppp-RNA and IFIT1 N216D or IFIT1 Q42E (Fig. S4L) . Whereas N216D had no impact on RNA binding, Q42E weakened the interaction and in translation assays, Q42E reduced IFIT1 activity similarly to Q42A (Fig. 5B, Right) . In other IFIT1-like proteins, such as rabbit IFIT1 and rabbit IFIT1B [both of which bind m7Gppp-RNA with ∼20 and 10 nM affinity, respectively (19) ], the natural Q42E variation is likely overcome by compensatory interactions.
Unlike IFIT1B from other species, human IFIT1B lacks an apparent function in RNA binding (12) . Sequence comparison shows that, along with Q42E, human IFIT1B has acquired additional substitutions that could impact RNA recognition: L150 is replaced with an Ala, which would affect cap ribose interactions, and R255 with Gln, which would disrupt a salt-bridge with the γ-phosphate (Fig. 3 E and F) . Supporting this theory, mutation of R255 in human IFIT1 (R255M) was shown to disrupt capped-and PPP-RNA binding (13, 18) . On the other hand, mice lack a bona fide IFIT1 ortholog and instead encode three copies of IFIT1B-like proteins (12) , currently annotated as mouse Ifit1, mouse Ifit1b, and mouse Ifit1c ( . The water at N7 ( §) appears only in the Gppp-bound form. The water at N1 appears to be in two conformations and was modeled as two water molecules. Ifit1b and Ifit1c harbor several substitutions that would disrupt RNA binding, such as R255G and Q42T in both, and R187H in Ifit1b (Fig. S5) . Consistent with this finding, pull-downs showed that mouse Ifit1c cannot bind capped RNA directly (18) .
IFIT1 Cap Binding Is Distinct from Canonical Cap-Binding Proteins.
The IFIT1 cap-binding mechanism described here is quite distinct from canonical cap-binding proteins such as eIF4E (34), capbinding complex (CBC) (35) , and VP39 (vaccinia virus N1 2′-O MTase) (36) . Through convergent evolution these proteins evolved a highly specific cap-binding slot between two aromatic side-chains that engage the methylated guanine in a cation-π sandwich (31) . Charge-charge interactions with the delocalized positive charge and van der Waals contacts with the N7-methyl also play a role (31) . In these proteins, the absence of N7-methylation and associated positive charge on the base results in >100-fold loss in binding affinity (37) . These proteins also rely on hydrogen bonds targeting groups at the m7G base periphery. The cumulative effect of these restrictions results in highly specific recognition of the cap in a single anti-conformation of m7G (Fig. 6 ).
In contrast, IFIT1 engagement of the cap is relatively less specific, permitting both syn-and anti-base orientations, as described above. Although IFIT1 does use one aromatic residue for cap stacking, the remainder of its sandwich is formed by aliphatic side chains (Leu-46, Thr-48, and Ile-183) rather than another aromatic residue. Therefore, the lack of an electron-rich, aromatic cap-binding slot reduces the dependence on an electron-deficient, N7-methylated base. Additionally, protein contacts with the N7-methyl are dispensable (e.g., the N216A mutant), and they are altogether absent when the cap is in the syn-configuration. Importantly, IFIT1 lacks any sequence specific hydrogen bonding from protein residues, and instead uses a more plastic, watermediated hydrogen-bonding network for base recognition.
Finally, at physiological pH m7G exists in an equilibrium between two forms: a positively charged "keto tautomer" and a zwitterionic "enolate tautomer" (in which N1 is deprotonated) (Fig. S4H) (34) . The canonical cap-binding proteins are highly selective for guanine as the base and in particular, its keto form. These aspects are enforced by two elements: (i) the cation-π sandwich, which is only compatible with an electron-deficient, positively charged keto tautomer (38) ; and (ii) Asp or Glu residues at one end of the cap-binding slot, which hydrogen bond with a protonated N1 and the N2-amino group. Conversely, IFIT1 does not form any keto-or enolate-specific interactions with the base, suggesting that IFIT1 is not selective for the tautomerization state, reinforcing the lack of guanine specificity.
Binding of Cap-Proximal Nucleotides. Recognition of the four RNA nucleotides following the cap is conformation-specific and can be divided into two distinct dinucleotide groups diverging between N2 and N3 (Fig. 2 C-E) . The RNA backbone lies along the superhelical axis of the protein, and is recognized by specific hydrogen bonds and salt bridges from protein residues targeting the 5′-phosphates and 2′-hydroxyls of N2 and N3 (Fig. S6 A and B) . In contrast, recognition of the bases is predominantly through sequence-nonspecific van der Waals and stacking interactions. The first dinucleotide (N1 and N2) adopts geometry similar to CpG dinucleotides found within Z-form RNA and UUCG tetraloops (39) , and is tightly sandwiched between multiple protein residues ( Fig. S6 A and C) . The second dinucleotide (N3 and N4) adopts A-form helical geometry with the bases also stacked upon each other and abutted by protein residues from above and below ( Fig.  S6 B and D) . The large water network inside the tunnel interacts with all groups of the RNA, and mediates both intermolecular protein-RNA and intramolecular RNA-RNA interactions (Fig. S6E) . Interestingly, a large part of this extensive water network is involved in protein-base contacts, allowing IFIT1 to recognize a wide variety of RNA sequences that may exist at the 5′-end of viral RNA. A small degree of sequence-dependent binding affinity variation may exist because there are two adenine-specific hydrogen bonds at N2 and N4 (Fig. S6 A and B) , although RNA binding assays show that adenosines are not strictly required at these positions.
The 3′-end of the RNA (N4) emerges from the C-terminal opening of the tunnel and points toward a positively charged, solvent-exposed groove formed by the pivot helices and the third subdomain (Fig. 7) . This surface is contiguous with the RNA-binding tunnel and also appears to contribute to RNA interactions because the analogous region in IFIT5 can apparently bind tRNA (14) . In IFIT1, the groove does play some role in RNA binding, as primer-extension toe-printing assays suggested that IFIT1 has a 6-to 8-nt footprint at the 5′-end of mRNA, and mutational analysis of this region had an impact on mRNA binding (19) . However, cocrystal structures of IFIT1 with longer oligonucleotides (6-8 nt in length) revealed extra electron density for only the 5′-phosphate of a fifth nucleotide, as was shown for IFIT5 (13) , suggesting that only the first four nucleotides are stably bound by IFIT1, whereas residues in the positively charged groove probably contribute to nonspecific RNA binding.
IFIT1 Senses Ribose 2′-O Methylation at N1 and N2.
The mRNA of higher eukaryotes is normally modified by ribose 2′-O methylation at N1 and N2 (40) . Whereas all cellular mRNAs are methylated at N1 in the nucleus by the endogenous Cap1-methyltransferase (CMTr1) (2) , ribose methylation at N2 arises from secondary methylation in the cytoplasm through the action of CMTr2 (3, 41) , and accompanies N1 methylation on up to 50% of cellular mRNAs (42, 43) . N1 ribose methylation is a molecular determinant of self that can protect mRNA from IFIT1/IFIT1B recognition (18, 19) , but the role of N2 methylation in this process is unknown. To gain additional insight into self-vs. nonself-mRNA discernment by IFIT1, and to explore the uncharacterized role of ribose N2 methylation in this process, we examined the interaction between human IFIT1 and differentially methylated RNA. Note that, to distinguish the naturally occurring Cap1 and Cap2 structures (m7GpppNmN-and m7GpppNmNm-) from capped RNAs that contain ribose N2 methylation only (m7GpppNNm-), we refer to the latter as Cap0 N2Me -RNA. When bound to IFIT1, N1 and N2 adopt a rare Z-RNA-like conformation that is dependent on their respective ribose conformations (Fig. S6F) (39) . Whereas N2 is in the favorable C3′-endo conformation, N1 adopts a C2′-endo conformation and places its 2′-OH in close proximity to the side chains of two highly conserved residues, R187 and Y157 (Fig. 8A and Fig.  S6A ). Modeling of ribose 2′-O methylation on N1 to mimic Cap1-mRNA shows that the methyl group would clash with these protein residues (Fig. 8A) . Rotating the methyl group away introduces a steric clash with the RNA itself and interferes with the water network. Interestingly, N2 ribose methylation is also predicted to disrupt RNA binding to IFIT1, because of hydrogen bonds with H289 and steric hindrance by Q290 ( Fig. 8A and Fig.  S6A ). Thus, the IFIT1 tunnel is restricted to interact with RNAs not methylated at these 2′-hydroxyls. Consistent with this finding, either N1 or N2 methylation of HCoV and GGG42 RNAs is sufficient to disrupt binding with up to 2.5 μM IFIT1 (Fig. 8B and Fig. S7 A and B) . Surprisingly, at the same concentrations, individual N1 or N2 methylation only partially reduced the interaction between IFIT1 and MHV RNA, and combining both was required to fully abolish binding for this sequence (Fig. 8B and Fig. S7 A-C) . This RNAdependent effect is likely because of the longer overhang and decreased secondary structure stability of the MHV sequence compared with HCoV/GGG42 (Fig. 1A and Fig. S1B ), allowing it to maintain relatively strong binding to IFIT1, even when modified with a single ribose methylation, and requiring the additive effect of multiple methylations (N1+N2) to avoid IFIT1 recognition. However, we cannot rule out the existence of RNA-sequence or other structural elements within MHV that intrinsically enhance its affinity for IFIT1. At higher protein concentrations (5 μM IFIT1) where nonspecific interactions may play a role, the additive effects of N1+N2 ribose methylations also became apparent for the GGG42 RNA (Fig. S7 D and E) .
Consistent with the above findings, single N1 or N2 methylation of the reporter mRNA reduced IFIT1 inhibitory activity in translation assays by ∼10-fold (IC 50 ∼ 1 μM) (Fig. 8C) , whereas translation of Cap1-and Cap0
N2Me
-mRNA was still strongly inhibited by 5 μM IFIT1. This finding intriguingly suggests that N1-or N2-methyl steric hindrance can be overcome at very high IFIT1 concentrations, possibly from nonspecific RNA interactions contributed by the solvent exposed groove of IFIT1. As before, combining N1 and N2 methylations (Cap2 reporter) resulted in a striking rescue of translational inhibition, restoring FF levels to 90% even in the presence of 5 μM IFIT1 (Fig. 8C) . Taken together, our combined structural and functional analysis confirms the role of N1 methylation in interfering with IFIT1 inhibitory activity, and reveals an analogous function for N2 methylation. Importantly, our data suggest that the combination of N1 and N2 methylation, as found in nearly half of endogenous mRNAs, produces an additive and potentially synergistic protective effect against IFIT1 recognition, which is particularly evident under circumstances where IFIT1 can overcome individual 2′-O methylation in an RNA-dependent or protein concentration-dependent manner.
To further confirm the importance of 2′-O methyl sensing for IFIT1 activity, we mutated the residues predicted to clash with N1 or N2 ribose methylations, and tested their impact on RNA binding and translational inhibition (Fig. 8 D and E) . At N1, Y157F had only a minor effect on capped RNA binding, but both R187H and R187A abolished the interaction. At N2, mutating either H289 (H289A) or Q290 (Q290E) partially reduced binding, and combining either mutant with Y157F (DM-YH, Y157F/ H289A; or DM-YQ, Y157F/Q290E) completely disrupted binding. Translation assays also showed reductions in IFIT1 inhibitory activity for all mutants, with R187H and the two double mutants having the greatest effect. It should be noted, however, that these residues are highly conserved (Fig. S4M) , and as such, play an integral role in general RNA binding that extends beyond 2′-O methyl sensing (Fig. S6 A and B) . Thus, capped-RNA recognition and 2′-O methyl sensing by IFIT1 are two tightly linked processes that have likely coevolved.
Functional Validation of IFIT1 Activity Against 2′-O Methyltransferase Deficient Human Coronavirus. Human IFIT1 has been shown to inhibit replication of viruses lacking N1 ribose 2′-O methylation, such as HCoV 229E bearing a D129A (DA) mutation in its viral 2′-O MTase gene (18) . Therefore, to functionally validate our results in a biological context, we tested the antiviral activity of IFIT1 RNAbinding mutants against wild-type HCoV 229E and HCoV 229E DA. First, we verified that the IFIT1 mutants used in cell-based assays (R187H, W147M, Y157F, and Q290E) disrupted the interaction with Cap0-HCoV RNA (Fig. S7F) . Next, we reconstituted Flp-In T-REx 293 IFIT1 knockout cells with human IFIT1 or IFIT1 mutants, and assayed HCoV growth in these cells (Fig. 8 F and G) . Although expression of a control protein (GFP) led to comparable accumulation of both wild-type and DA virus in the supernatant of infected cells, expression of IFIT1 significantly reduced growth of the DA mutant virus, but not wild-type virus (Fig. 8F) . In contrast, IFIT1 R187H, which disrupts interactions with the cap ribose and bridging triphosphate (Fig. 3 E and F) , was unable to impair HCoV 229E DA virus growth (Fig. 8F) . Similarly, W147M, which disrupts cap recognition, or Y157F and Q290E, which impair binding to Cap0-HCoV RNA (Fig. S7F) , lost their antiviral activity against HCoV 229E DA (Fig. 8G) . Thus, IFIT1 binding to 2′-O unmethylated viral RNA is required for its antiviral properties.
Discussion
The ability of many viruses to cap their mRNA and mimic the host's allows them to hijack a cell's translational machinery and replicate new virus particles. To counteract this, host cells have evolved as part of their antiviral program, the IFIT proteins. By competing with eIF4E/eIF4F for binding to capped RNA, IFIT1 can prevent viral propagation by latching onto the ends of mRNA and preventing assembly of ribosomal initiation complexes (18, 19) . Whereas recognition of the cap by eIF4E and other cap-binding proteins occurs in a highly specific manner (31, 37), we surprisingly found that recognition of the cap moiety by IFIT1 is instead nonspecific with regards to both sequence and structure. Through its highly water-filled cap-binding pocket, IFIT1 can accommodate not only bona fide cap in different orientations, but also an unmethylated cap, adenine cap, and presumably other structures too. This built-in plasticity may in part be to allow IFIT1 to maintain a broad spectrum of antiviral activity, and to thwart the ability of viral structures to rapidly evolve. Another possibility is that IFIT1 genes simply have not had enough time to evolve exquisite cap specificity, because they emerged relatively recently in evolution [jawed vertebrates (12) ] compared with eIF4E and CBC, which are essential genes in all eukaryotes (34, 35) . Regardless, the penalty for this plasticity is likely a reduction in affinity for the cap moiety and in this respect, the recognition of nucleotides beyond the cap provides IFIT1 the additional affinity required to compete with an otherwise very tight eIF4F-5′-cap complex.
The recognition of cap-proximal nucleotides by IFIT1 also plays a critical role in discerning self from nonself. Our structural analysis revealed that IFIT1 forms a tight interacting surface around the ribose 2′-hydroxyls of N1 and N2, thus preventing recognition of endogenous mRNAs methylated at these positions and restricting IFIT1 activity to unmethylated viral mRNAs. This finding is supported by a comprehensive gel-shift analysis that showed a preference for recognizing Cap0 structures over N1 or N2 methylated RNA, in vitro translation assays that showed a reduction in IFIT1's ability to inhibit translation of N1 or N2 methylated mRNA reporters, and human coronavirus infectivity assays that showed enhanced IFIT1 antiviral activity when viral N1 methylation was mutated. In this way, IFIT1 effector function complements RIG-I receptor activity (summarized in Fig. S7 H-J) , as RIG-I detects blunt-ended, base-paired PPP-and Cap0-RNAs to up-regulate IFIT1 and other ISGs (8, 9) . Cellular N1 methylation was generally thought to be the primary determinant of self, protecting endogenous mRNA from IFIT1 recognition, but we discovered that the ability to discern between Cap0 and Cap1 structures is diminished for one of our RNAs (MHV) (Fig. 8B) , an effect that is possibly linked to its 5′-sequence or secondary structure. This finding is in accordance with a recent study by Daugherty et al., who demonstrated that human IFIT1 can target both Cap0 and Cap1 mRNAs when overexpressed in a yeast system (12) . Furthermore, while this manuscript was under revision, Young et al. similarly showed that N1 methylation of a reporter gene only partially reduced its sensitivity to human IFIT1 in an in vitro translation system (44) . Interestingly, using viral mRNA in the same system, Young et al.
also noted potential RNA-dependent effects for N1 methylation. Taken together, these observations lead to the conclusion that N1 methylation alone may not be enough to protect all endogenous mRNAs from IFIT1, and that there are other determinants of self that govern IFIT1 activity.
Our structural and functional analysis reveals that N2 methylation by CMTr2 could fulfill this role, providing an additional safeguard against aberrant recognition of mRNAs that are otherwise susceptible to IFIT1 (Fig. 8B) . However, as Cap2 structures are not as ubiquitous as Cap1 (40), other elements may prevent self-recognition. For example, actively translating mRNAs are generally found in preformed mRNP complexes and, as indicated by our order-of-addition experiment (Fig. 1C) , would be protected from IFIT1 competition. Similarly, newly synthesized mRNAs undergo a pioneer round of translation directed by the CBC (45) , which may also offer protection from IFIT1. Adenosine N6-methylation of the first transcribed nucleotide is another modification that accompanies ribose N1 methylation on ∼20-30% of cellular mRNAs, in the form of N6,O2′-dimethyladenosine (m6Am) (46, 47) . Our structure suggests that m6Am could protect self-mRNAs by disrupting water-mediated interactions and impinging on nearby residues (Fig. S6 A and E) , and thus merits further investigation. Finally, cap-proximal secondary structure elements could combine with mRNA modifications to further prevent self-recognition.
To what extent do viruses exploit these mechanisms to alter IFIT1 activity? Our observations support the model whereby viral N1 methylation evades or dampens IFIT1 activity (Fig. 8 F  and G) , and is consistent with previous studies showing enhanced sensitivity of coronaviruses and flaviviruses to IFIT1 when viral N1 methylation was mutated (18, 23, 24, 26) . Similarly, Young et al. recently showed that parainfluenza virus type 5 (PIV5) was more sensitive to human IFIT1-mediated restriction than PIV3, partly because PIV5 mRNAs were not completely N1-methylated during infection (44) . On the other hand, vesicular stomatitis virus (VSV) has been shown to uniformly N1-methylate its mRNAs in vivo (48, 49) , yet it remains sensitive to IFIT1 restriction (12) . One explanation is that the short and potentially unstructured 5′ UTRs of VSV mRNAs could allow IFIT1 to overcome N1 methylation (as described here for MHV RNA). Alternatively, VSV mRNAs may display another pattern specifically recognized by IFIT1 (as proposed by Daugherty et al.), such as RNA-sequence or -structural elements (12) . Further work is needed to validate either notion, and to determine if this ability to overcome viral N1 methylation is an adaptation that allows IFIT1 to target other Cap1-containing viruses, or if it is restricted to VSV and related viruses.
IFIT1B (which includes mouse Ifit1) is the only other IFIT family member known to specifically recognize capped RNAs to inhibit viral replication (18, 19) . Our analysis supports the notion that both proteins use a similar mode of cap-recognition, and thus should display overlapping antiviral activities. However, recent evidence suggested otherwise (12) . Based on our structural and functional data, we propose that both IFIT1 and IFIT1B can target Cap0-containing viruses, but they may differ in their sensitivity to cap-proximal modifications, such as methylation, RNA-sequence, or RNA-structure. These differences and underlying molecular mechanisms are not entirely clear yet, but one possibility is that the ability to overcome N1 methylation in an RNA-dependent manner could distinguish IFIT1 from IFIT1B proteins, and may explain why IFIT1 overexpression inhibited wild-type VSV replication (a Cap1-containing ssRNA virus), whereas IFIT1B overexpression did not (12) . Regardless, in humans IFIT1B appears to be nonfunctional, and has been deleted or pseudogenized in several other mammals, consistent with the notion that widespread viral evasion strategies (e.g., N1 methylation) have generally defeated IFIT1B (12), whereas IFIT1 was retained possibly because of its adaptable nature.
Taken together, through a relatively nonspecific cap-binding pocket and a potentially plastic RNA binding mechanism, IFIT1 appears to have grafted adaptability onto an otherwise germ-line-encoded member of the innate immune system, to broadly defend against rapidly evolving viral pathogens. At the same time, the host evolved multiple mechanisms that combine to limit detrimental IFIT1 activity against endogenous mRNAs. Clearly, further work is needed to validate the physiological relevance of these notions, particularly with respect to understanding how IFIT1 can overcome N1 methylation in an RNA-dependent manner, the differential specificities of IFIT1 and IFIT1B proteins, and if viruses exploit CMTr2 and other enzymes to modify their mRNA and evade IFIT1. Finally, it has been established that human IFIT1 can form complexes with other IFIT family members (IFIT2 and IFIT3) and several host factors (17) , which could play a role in modulating self-vs. nonself-mRNA recognition and translational inhibition. Our structural and functional analysis of IFIT1-capped RNA interactions will provide a framework for future structure-guided studies of IFIT function. Moreover, these efforts will provide important contributions to the development of mRNA therapeutics and to vaccine design, as emerging research suggests that rendering viruses more susceptible to IFIT1-like antiviral responses, by inhibiting their mRNA 2′-O methylation or modifying their 5′-secondary structure, is a strategy for the rapid development of live, attenuated vaccines (e.g., refs 21-24).
Materials and Methods
Detailed discussions of the materials and methods used in this study are provided in SI Materials and Methods.
Protein Expression and Purification. IFIT proteins, RNMT (Human N7-MTase), and TbMTr2 (Trypanosoma brucei Cap2 MTase) were expressed in Escherichia coli, and purified by Ni-affinity, ion-exchange, and size-exclusion chromatography. CMTr2 (Human Cap2 MTase) was expressed in Sf9 insect cells and purified by Ni-affinity and size-exclusion chromatography.
IFIT1 Crystallography. IFIT1 monomeric mutants (L457E/L464E or N216A/L457E/ L464E) were purified to homogeneity and mixed with molar excess chemically synthesized oligos (see SI Materials and Methods for synthesis, purification, and MS of oligos) and crystallized in 27-32% (vol/vol) PEG 200, 0.1 M Tris pH 8.1, and 200 mM CaCl 2 . Crystals were flash-frozen in liquid nitrogen without additional cryoprotection, and diffraction data were collected at Canadian Light Source beamline 08ID-1 (Table S1 ). Initial structures were determined by molecular replacement, subsequent structures by rigid body refinement.
RNA EMSA. RNAs for EMSAs were prepared using T7 RNA polymerase and purified by denaturing PAGE. Appp-GGG42 was capped cotranscriptionally; other modifications were performed with CIP (New England Biolabs), vaccinia capping enzyme (New England Biolabs), Cap1 2′-O MTase (New England Biolabs), or home-made CMTr2 or TbMTr2. All 5′ caps and RNA sequences were confirmed by LC/MS. RNA sequences and mass spec summary are in Tables S2 and S3 , respectively. The 3′-end labeling of m7Gppp-43 with pCp-Cy5 was performed with T4 RNA ligase (New England Biolabs). For EMSAs, purified proteins and RNA were mixed at the indicated concentrations in each figure, and resolved by native PAGE [1× TBE, 10% (vol/vol) gels]. Bands were visualized with SYBR Gold and UV imaging (unlabeled RNA), or with a Typhoon R3 imager (for pCp-Cy5 labeled RNA). Band densitometry was performed with ImageJ.
Reporter mRNA Preparation and in Vitro Translation Assay. The bicistronic reporter (5′-UTR sequence is in Table S2 ) was in vitro transcribed with SP6 RNA polymerase in the presence of either m7GpppG, GpppG, or ApppG RNA Cap Analog (New England Biolabs). N1/N2 methylations were performed post transcriptionally using mRNA Cap1 2′-O MTase (New England Biolabs) and/or TbMTr2. In vitro translations were set up at a final volume of 10 μL with 4 ng/μL reporter mRNA (∼4 nM final) and 1 μL protein in untreated Krebs-2 extracts, and performed as described in SI Materials and Methods. 
